EZH2 is the functional enzymatic component of the Polycomb Repressive Complex 2 (PRC2) involved in a wide range of glioma processes, including cell cycle, invasion, GSC maintenance, drug and RT resistance (Yin et al., 2016). Here, EZH2 is linked to central nervous system cancer.